Tradestie Institutional Equity Comparison Engine

STRO vs CDT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

STRO Overall Edge

STRO Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sutro Biopharma, Inc. (STRO) driven by superior Valuation, Momentum & Technical, Options & Structure while CDT counters with relative strength in Growth & Margin. Fundamentally, STRO trades at 10.0x Forward P/E with -254.7% operating margin (-6.1% YoY revenue) versus CDT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, STRO sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against CDT sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner STRO
STRO 10.0x vs CDT N/M Fwd P/E
Growth & Margin Winner CDT
Op Margin -254.7% vs 0.0% ยท YoY -6.1% vs +0.0%
Momentum & Technical Winner STRO
1Y +845.0% vs -86.8% ยท 52W Pos 18% vs 2%
Options & Structure Winner STRO
UNCLASSIFIED (<1st %ile IV) vs BREAKDOWN (N/A IV)
STRO NASDAQ
Sutro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
$8.60
-1.38% 1D
Market Cap $144.8M
1M Return -16.42%
1Y Return +845.05%
Forward P/E 10.0x
Unified AI Score
44.1 / 100 HOLD
Tech 30.0 Fund 48.0 Flow 50.0 Mom 68.9
CDT NASDAQ
CDT Equity Inc. Common Stock
Pharmaceutical Preparations
$0.23
-13.89% 1D
Market Cap $507,528
1M Return +76.79%
1Y Return -86.78%
Forward P/E N/M
Unified AI Score
31.6 / 100 SELL
Tech 15.0 Fund 37.0 Flow 50.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: STRO +845.05% CDT -86.78% Spread: +931.83 pp (STRO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
STRO TTM Op. Margin: -254.7% CDT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on STRO vs CDT. Trailing 12-month operating profitability (STRO -254.7% vs CDT 0.0%) and valuation multiples (STRO 10.0x vs CDT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: STRO (6) vs CDT (3)
Institutional Metric STRO CDT Criterion Row Winner
Market Capitalization Scale $144.8M $507,528 Larger Scale STRO
Trailing P/E Ratio Valuation 10.0x N/M Lower Multiple STRO
Forward P/E Ratio Valuation 10.0x N/M Lower Multiple STRO
Revenue Growth (YoY) Growth -6.1% +0.0% Higher Growth CDT
Operating Margin (TTM) Profitability -254.7% 0.0% Higher Margin CDT
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -1810.0% -69.7% Higher ROE CDT
52-Week Range Position Momentum 18% ($1โ€“$44) 2% ($0โ€“$11) Stronger Trend STRO
Beta / 30D Volatility Risk Regime 1.46ฮฒ ยท 76% Vol -17.75ฮฒ ยท 10175% Vol Lower Realized Risk STRO
Unified Institutional Score Composite Signal 44.1 / 100 (HOLD) 31.6 / 100 (SELL) Higher Composite STRO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full STRO vs CDT Buy Guide
STRO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live STRO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CDT BREAKDOWN
163d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CDT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither STRO nor CDT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.